PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Brain Res Rev. Author manuscript; available in PMC Jun 24, 2012.
Published in final edited form as:
PMCID: PMC3109119
NIHMSID: NIHMS265056
Oligodendrogenesis in the subventricular zone and the role of epidermal growth factor
Oscar Gonzalez-Perez and Arturo Alvarez-Buylla
Oscar Gonzalez-Perez, Laboratory of Neuroscience. School of Psychology. University of Colima. Colima, Col. 28040, Mexico;
Corresponding authors: Oscar Gonzalez-Perez, M.D., Ph.D., Facultad de Psicologia, Universidad de Colima, Av. Universidad 333, Colima, COL 28040, Mexico, osglez/at/gmail.com And / Or Arturo Alvarez-Buylla, Ph.D., Department of Neurosurgery and Institute for Regeneration Medicine. University of California, San Francisco. Box 0525, San Francisco, CA 94143, abuylla/at/stemcell.ucsf.edu
Demyelinating diseases are characterized by an extensive loss of oligodendrocytes and myelin sheaths from axolemma. These neurological disorders are a common cause of disability in young adults, but so far, there is no effective treatment against them. It has been suggested that neural stem cells (NSCs) may play an important role in brain repair therapies. NSCs in the adult subventricular zone (SVZ), also known as Type-B cells, are multipotential cells that can self-renew and give rise to neurons and glia. Recent findings have shown that cells derived from SVZ Type-B cells actively respond to epidermal-growth-factor (EGF) stimulation becoming highly migratory and proliferative. Interestingly, a subpopulation of these EGF-activated cells expresses markers of oligodendrocyte precursor cells (OPCs). When EGF administration is removed, SVZ-derived OPCs differentiate into myelinating and pre-myelinating oligodendrocytes in the white matter tracts of corpus callosum, fimbria fornix and striatum. In the presence of a demyelinating lesion, OPCs derived from EGF-stimulated SVZ progenitors contribute to myelin repair. Given their high migratory potential and their ability to differentiate into myelin-forming cells, SVZ NSCs represent an important endogenous source of OPCs for preserving the oligodendrocyte population in the white matter and for the repair of demyelinating injuries.
Keywords: Oligodendrocyte, NG2 glia, Myelin, Brain repair, Demyelinating disease, Oligodendrocyte precursors, Epidermal growth factor
Oligodendrocytes are neuroglial cells that produce a functional segmentation of the axolemma, promote axon maturation and provide an electric insulation of axons in the central nervous system (Colello et al., 1994; Mathis et al., 2001). Telencephalic oligodendrocytes derive from progenitors that migrate from medial ganglionic eminence and the anterior entopeduncular area (Nery et al., 2001; Richardson et al., 2006). In the adult brain, mature myelinating oligodendrocytes are continuously produced from local oligodendrocyte precursor cells (OPCs) residing in the brain parenchyma (Gensert and Goldman, 1997; Fancy et al., 2004), and from cell precursors located in the subventricular zone (Nait-Oumesmar et al., 1999; Picard-Riera et al., 2002; Menn et al., 2006). Parenchymal OPCs express the NG2 proteoglycan (Stallcup and Beasley, 1987; Nishiyama et al., 2002), the ganglioside GD3 (LeVine and Goldman, 1988), and the platelet-derived growth factor-alpha receptor (PDGFRα) (Pringle et al., 1992). These NG2+ / GD3+ / PDGFRα+ precursors actively respond to demyelinating lesion by proliferating and differentiating in mature oligodendrocytes that restore myelin sheaths, but they do not migrate extensively (Gensert and Goldman, 1997; Fancy et al., 2004).
Demyelinating diseases comprise a group of progressive disorders characterized by an extensive loss of oligodendrocytes and myelin sheaths from nerve fibers. Multiple sclerosis is the most common demyelinating disease and an important cause of disability in young adults. Women are affected about two to three times more often than men, and that is worldwide. To date, there is no effective treatment for these diseases. Nevertheless, it has been suggested that neural stem cells (NSCs) represent an endogenous source of cells for brain repair that circumvents immune rejection (Goldman and Windrem, 2006; Taupin, 2006; Lim et al., 2007). NSCs are multipotent cells that can self-renew and differentiate into all neural cell types, i.e. neurons, astrocytes and oligodendrocytes. These multipotent cells are present in the adult mammalian brain and are restricted to specialized niches (Doetsch, 2003b; Kriegstein and Alvarez-Buylla, 2009). The most extensive such niche is the subventricular zone (SVZ) located along the walls of the lateral ventricles in the forebrain (Doetsch et al., 1997; Doetsch, 2003a). The SVZ contains slowly dividing astrocytic neural progenitors also known as Type-B cells. These germinal astrocytes give rise to actively proliferating transit-amplifying cells named Type-C cells, which in turn generate immature neuroblasts (Type-A cells) (Figure 1) (Doetsch et al., 1997; Doetsch et al., 1999). Type-A cells are ensheathed by the processes of Type B cells and form tangential chains of neuroblasts along the anterior extension of the SVZ. At the rostral region of SVZ, these chains of migrating neuroblasts merge and compose the rostral migratory stream (RMS) (Lois and Alvarez-Buylla, 1994; Lois et al., 1996). Then, Type-A cells reach the olfactory bulb and mature into distinct interneurons (Lois and Alvarez-Buylla, 1993, 1994; Merkle et al., 2007). In addition to olfactory interneurons, it has been demonstrated that Type-B cells of the SVZ are able to produce myelinating oligodendrocytes, which populate the white matter tracts of corpus callosum, fimbria fornix and striatum (Menn et al., 2006).
Figure 1
Figure 1
The subventricular zone (SVZ) niche
The epidermal growth factor (EGF) is an important regulator of proliferation, migration and cell fate of adult NSCs (Reynolds and Weiss, 1992; Vescovi et al., 1993; Gritti et al., 1995; Craig et al., 1996). Increasing evidence indicates that overstimulation of EGF signaling pathway in the adult SVZ significantly increases the number of OPCs (Aguirre et al., 2007; Gonzalez-Perez et al., 2009). These SVZ-derived OPCs can migrate long distances and contribute to re-myelination of white matter tracks. High migratory ability and remyelination capacity are two fundamental properties in the design of cell repair therapies for demyelinating diseases (Blakemore and Franklin, 2000). Here, we describe the role of the SVZ as a source of migratory OPCs and discuss the important oligodendrogenic effect of EGF on adult NSCs to promote myelination and white matter repair.
As mentioned above, NSCs are multipotent self-renewing progenitors residing in the SVZ that continually replace local interneurons (Reynolds and Weiss, 1992; Lois and Alvarez-Buylla, 1993, 1994). Adult NSCs have been demonstrated in many vertebrate species including birds, reptiles, mice, rats, rabbits, voles, dogs, cows, monkeys and humans (Lewis, 1968; Blakemore, 1969; Blakemore and Jolly, 1972; McDermott and Lantos, 1990; Eriksson et al., 1998; Huang et al., 1998; Gould et al., 1999; Kornack and Rakic, 2001; Garcia-Verdugo et al., 2002; Rodriguez-Perez et al., 2003; Sanai et al., 2004). In adult humans, NSCs have been isolated from the SVZ (Sanai et al., 2004) and the subcortical white matter (Nunes et al., 2003).
As indicated above, the SVZ generates young neurons that migrate tangentially to the olfactory bulb where they mature into different types of local interneurons. In parallel, SVZ neural progenitors also generate OPCs that migrate radially to the neighboring white matter tracts of corpus callosum, septum and fimbria fornix and differentiate into myelinating oligodendrocytes (Nait-Oumesmar et al., 1999; Picard-Riera et al., 2002; Jackson et al., 2006; Menn et al., 2006; Gonzalez-Perez et al., 2009). The SVZ NSCs, also known as Type-B cells, are a subpopulation of astrocytes that express the intermediate filament component glial fibrillary acidic proteic (GFAP) (Doetsch et al., 1999; Garcia et al., 2004), LeX (Capela and Temple, 2002) and Nestin (Rietze et al., 2001). Interestingly, young astrocytes, isolated from multiple brain regions before postnatal day 10, can function as neural stem cells in vitro (Laywell et al., 2000). After that time, only the SVZ astrocytes appear to retain this NSC capacity (Lim and Alvarez-Buylla, 1999). Remarkably, Type-B stem cells are not homogeneous, but are restricted in their neurogenic potential (Merkle et al., 2007). Thus, Type-B cells in different locations appear to generate different types of neurons.
3.1 Cytoarchitecture in the SVZ
In the adult human brain, SVZ astrocytes are not found adjacent to the ependymal layer. Instead, human SVZ astrocytes accumulate in a band or ribbon separated from the ependyma by a gap that is largely devoid of cells (Sanai et al., 2004; Quinones-Hinojosa et al., 2006). A recent work has revealed a unique center-surround organization, denominated as ‘pinwheel’, for ependymal cells and Type-B cells within ventricular walls (Mirzadeh et al., 2008). Pinwheel's cores contain the apical endings of Type-B cells and in its periphery two types of ependymal cells: multiciliated (Type-E1 cells) and bi-ciliated (Type-E2 cells) (Figure 1). Interestingly, SVZ Type-B cells extend a minute apical ending to directly contact the ventricle and a long basal process ending on blood vessels (Figure 1)(Mirzadeh et al., 2008; Shen et al., 2008). These contacts are important because it has been suggested that extracellular matrix (Mercier et al., 2002) or soluble factors (Leventhal et al., 1999; Shen et al., 2008; Tavazoie et al., 2008) secreted by blood vessels play an important role in regulating adult neurogenesis. Recently, it has been demonstrated that transplanted NSCs integrate into the SVZ and associate preferentially with the vasculature by a differential interaction between the stromal-derived factor 1, secreted by endothelial cells, and the CXC chemokine receptor 4 expressed by SVZ cells (Kokovay et al., 2010). However, it is not known whether these contacts and the pinwheel organizations may play a role in the regulation of oligodendrogenesis in the SVZ. Although, the signals underlying regulation of the SVZ progenitors and their activation remain unknown, epidermal (EGF), fibroblast (FGF) and platelet-derived (PDGF) growth factors are important mitogenic regulators for multipotent stem cells in the SVZ (Reynolds and Weiss, 1992; Vescovi et al., 1993; Gritti et al., 1995; Craig et al., 1996; Gritti et al., 1999; Jackson et al., 2006).
NSCs from the adult SVZ can be grown as a cell suspension in the presence of growth factors. Under these in vitro conditions, NSCs form spherical structures called neurospheres containing cells that are not only be able to self-renew (forming more neurospheres), but also to differentiate into neurons, astrocytes and oligodendrocytes (Reynolds and Weiss, 1992; Vescovi et al., 1993; Gritti et al., 1996). Evidence indicates that neurospheres grafted into the brain can produce a number of myelinating oligodendrocytes (Pluchino et al., 2003). However, under normal conditions, the production of oligodendrocytes in the SVZ is scarce (Menn et al., 2006). Interestingly, demyelinating lesions in the neighboring white matter can significantly increase the generation of OPCs from SVZ progenitors (Nait-Oumesmar et al., 1999; Picard-Riera et al., 2002; Menn et al., 2006). Chordin appears to be one of the responsible signals, which re-directs GAD65 and doublecortin SVZ progenitors from neuronal to glial fates, generating new oligodendrocytes in a demyelinated corpus callosum (Jablonska et al., 2010). In patients suffering from multiple sclerosis, the human SVZ shows an increase in the number of PSA-NCAM+ / Sox10+ / Olig2+ progenitors, which suggests that human SVZ respond to demyelinating lesions by increasing the production of OPCs (Nait-Oumesmar et al., 2007).
4.1 SVZ astrocytes give rise to oligodendrocytes
Type-B cells in the SVZ are also the primary progenitors of new oligodendrocytes (Menn et al., 2006). This was demonstrated by labeling SVZ astrocytes in transgenic mice (GFAP-tva mice) that express the receptor for an avian retrovirus (RCAS) under control of the GFAP promoter (Holland and Varmus, 1998). Using these transgenic mice, the lineage derivatives of dividing astrocytes can be traced using engineered avian RCAS retroviruses carrying an inheritable reporter gene (Figure 2). The SVZ astrocytes and their progeny are permanently labeled with this method and generate oligodendrocytes, which migrate to the corpus callosum and the white matter tracts in the striatum and fimbria fornix (Menn et al., 2006). Interestingly, SVZ astrocytes, but not parenchymal astrocytes can generate oligodendrocytes in vivo (Menn et al., 2006; Gonzalez-Perez et al., 2009) or in vitro (Gonzalez-Perez and Quinones-Hinojosa, 2010).
Figure 2
Figure 2
Origin of oligodendrocytes in the SVZ
4.2 Role of Olig2 transcription factor in SVZ oligodendrogenesis
Oligodendrogenesis in the SVZ appears to be mediated by a transit-amplifying progenitor (Type-C cell) that expresses the transcription factor Olig2 (Hack et al., 2005; Menn et al., 2006), which encodes basic helix-loop-helix transcription factor proteins that are crucial in the generation of OPCs (Rowitch, 2004). In the ventral embryonic forebrain, Olig2 expression and OPC formation are negatively regulated by Dlx homeobox transcription factors (Dlx1 and Dlx2) that determine neuronal cell fate acquisition (Petryniak et al., 2007). In the adult brain, Olig2 expression has been reported in OPCs and mature oligodendrocytes in the white matter (Ligon et al., 2004; Rowitch, 2004). Olig2-expressing Type-C cells may give rise to highly migratory OPCs that leave the SVZ and populate the corpus callosum, striatum and fimbria fornix, where they differentiate into NG2 glia and myelinating oligodendrocytes (Figure 2). Nevertheless, the number of SVZ-derived oligodendrocytes is limited as compared to the large number of new neurons generated by Type-B astrocytes. However, as mentioned above, the amount of oligodendrocytes produced in the SVZ can be increased by a demyelinating lesion. This suggests that external signals promote the gain-of-function of Olig2 in the SVZ (Maire et al., 2010), which stimulates oligodendrogenesis and myelination (Nait-Oumesmar et al., 1999; Picard-Riera et al., 2002; Menn et al., 2006; Gonzalez-Perez et al., 2009). Intracerebroventricular infusion of Noggin, an endogenous antagonist of bone morphogenic protein 4 (BMP4), increases the number of SVZ-derived oligodendrocytes (Colak et al., 2008; Cate et al., 2010). Endothelin-1, an astrocyte-derived signal, also regulates the migration and differentiation of OPCs (Gadea et al., 2009). A recent study indicates that glutamatergic inputs from demyelinated axons in the corpus callosum appears to signal OPCs migration from the SVZ and promotes axonal remyelination (Etxeberria et al., 2010). Thus, adult SVZ actively responds to demyelinating lesions and increases the number of OPCs generated, which contribute to repair axonal demyelination.
The epidermal growth factor is a small protein (6045 Da) with three intramolecular disulfide bonds and 53 amino acid residues (Cohen and Taylor, 1974; Carpenter and Cohen, 1979). The human EGF has a strong sequential and functional homology with the transforming growth factor alpha, which also binds to EGFR (Povlsen, 2008). EGF acts by binding with high affinity to the EGFR on the cell membrane that triggers the intrinsic protein-tyrosine kinase activity (Povlsen, 2008). Tyrosine kinase activity, in turn, stimulates a signal transduction cascade that increases intracellular calcium concentrations, promotes glycolysis and induces gene expression, which ultimately leads to DNA synthesis and protein production (Povlsen, 2008, 2010).
EGF can induce proliferation in a subpopulation of SVZ Type B stem cells and in the transit-amplifying Type-C cells (Doetsch et al., 2002). This appears to be mediated by the Notch and EGFR pathway interaction, which regulates the number and self-renewal of NSCs (Aguirre et al., 2010). The identity of the endogenous ligand for EGFR signaling is probably TGF-alpha, which is present in the choroid plexus (Seroogy et al., 1993; Tropepe et al., 1997). Overexpression of the EGFR confers migratory properties to non-migratory postnatal neural progenitors (Aguirre et al., 2005; Aguirre et al., 2007; Aguirre and Gallo, 2007; Gonzalez-Perez et al., 2009; Gonzalez-Perez and Quinones-Hinojosa, 2010). In the developing cortex and radial migration in the olfactory bulb, EGF mediates chemotactic migration (Caric et al., 2001). In the developing retina, embryonic cortical ventricular zone and early postnatal SVZ, the overexpression of EGFR results in precursors adopting a glial rather than a neuronal lineage (Lillien, 1995; Burrows et al., 1997; Petratos et al., 2004). It has been suggested that asymmetric segregation of EGFR during mitosis is responsible for glial fate restriction to a subpopulation of daughter cells (Sun et al., 2005). However, the signals underlying regulation of the primary stem cells and their activation remain to be elucidated, but it is clear that EGF plays an important role in normal cell growth, proliferation, migration and differentiation of neural cell lineages.
5.1 EGF induces SVZ astrocytes to generate oligodendrocyte precursors
Increasing evidence indicates that EGF is a key regulator of oligodendrocyte production (Aguirre et al., 2007; Aguirre and Gallo, 2007). EGFR overexpression in SVZ during early postnatal development also expands a population of NG2+Mash1+Olig2+ progenitors and enhances oligodendrocyte generation (Aguirre et al., 2005). A recent study shows that intracerebral infusion of EGF increases 300-400% the number of myelinating oligodendrocytes derived from SVZ astrocytes. Using the RCAS/GFAP-tva mouse system to label Type-B cells prior to EGF infusion, it was shown that the SVZ endogenous stem cells produce a 9.6-fold increase in the number of OPCs. Upon EGF removal these SVZ OPCs give rise to oligodendrocytes in both the normal and the injured brain (Gonzalez-Perez et al., 2009). Remarkably, this capacity appears to be restricted to SVZ astrocytes, because the labeling of astrocytes in cortex, corpus callosum or striatum with the RCA-Gtva system never resulted in labeled oligodendrocytes (Gonzalez-Perez et al., 2009). EGF increases the total number of BrdU-expressing astrocytes and Dlx-2 progenitors in the SVZ and promotes oligodendrogenesis, which occurs at the expense of neuroblast production (Doetsch et al., 2002; Gonzalez-Perez et al., 2009; Gonzalez-Perez and Quinones-Hinojosa, 2010). Instead, EGF induces the production of highly migratory cells that express Olig2 and Nestin (Figure 3 A-D). In addition, these cells also express NG2 and PDFGRα, a phenotype consistent with OPCs (Stallcup and Beasley, 1987; Pringle et al., 1992; Nishiyama et al., 2002). The newly generated OPCs migrate extensively following white matter tracts and the blood vessels close to the SVZ (Figure 3E). Interestingly, after EGF withdrawal the SVZ-derived OPCs stop migrating and differentiate into myelinating oligodendrocytes into the corpus callosum, striatum and fimbria fornix (Figure 4 A-B). In addition, the EGF stimulation of SVZ astrocytes generates NG2+ cells in the white and gray matter (Figure 4 C). NG2-expressing cells, also known as synantocytes (Wigley and Butt, 2009) or polidendrocytes (Nishiyama et al., 2009), are involved in brain scar formation and remyelination (Zawadzka et al., 2010). NG2-expressing cells are likely functionally diverse. In fact, a subpopulation of NG2+ cells expresses AMPA receptors and plays a role in glutamatergic synaptic signaling in the hippocampus, corpus callosum and cortex (Bergles et al., 2010). To date, it is not known whether the NG2-expressing cells derived from EGF stimulation in the SVZ are a heterogeneous subpopulation of NG2-expressing glia. Thus, EGF on adult NSCs may play a significant role in the design of brain repair therapies. Interestingly, the pro-oligodendrogenic effect of EGF on SVZ astrocytes is a dose-dependent phenomenon and, even at high doses of EGF, parenchymal astrocytes are not able to produce OPCs (Gonzalez-Perez and Quinones-Hinojosa, 2010). Taken together, this evidence indicates that EGF signaling plays an important role in cell fate choice on the SVZ Type-B cells and increases the production of highly migratory OPCs, which populate white matter tracts and contribute to the repair demyelinating lesions. The effects of exogenous EGF on the cell-fate of SVZ progenitors and oligodendrocyte generation are summarized in the figure 5.
Figure 3
Figure 3
EGF increases the production of Oligodendrocyte precursors in the SVZ
Figure 4
Figure 4
EGF removal induces SVZ-derived OPCs to differentiate into oligodendrocyte lineage
Figure 5
Figure 5
Hypothetical model of EGFR stimulation in the SVZ
5.2 Potential pitfalls of EGFR overstimulation into the brain
EGF is a mitogenic substance used in esthetic and reconstructive medicine because it promotes proliferation, growth and regeneration of epidermal tissues, such as skin (Franklin and Lynch, 1979; Jijon et al., 1989; Mustoe et al., 1991), cornea (Petroutsos et al., 1984), nasal mucosa (Hosemann et al., 1991) and tympanic membrane (Guneri et al., 2003). Experimental models have suggested a potential role of EGF as a treatment option for lung injuries (Lindsay, 2010), DNA double-strand break repair (Lindsay, 2010), stroke (Kolb et al., 2007) and demyelinating lesions (Aguirre et al., 2007; Gonzalez-Perez et al., 2009). Nevertheless, some evidence indicates that EGF stimulation may have undesirable effects. Long-lasting constitutive EGFR signaling in OPCs may lead to diffuse hyperplasia in postnatal white matter (Ivkovic et al., 2008). Other studies have found polyp-like formation after a long-lasting EGF infusion (Kuhn et al., 1997). There is also evidence that EGFR signaling plays a role in tumor progression. Approximately 50% of high-grade astrocytomas demonstrate EGFR amplification, which may drive the malignization process of glioblastomas (Maher et al., 2001; Wechsler-Reya and Scott, 2001). Olig2 and tenascin expression has been reported in brain tumors (Marie et al., 2001; Ligon et al., 2004). Interestingly, EGF infusion up-regulates the expression of tenascin (Doetsch et al., 2002) and Olig2, but did not generate glioma-like masses (Gonzalez-Perez et al., 2009). Instead, EGF-produces diffuse infiltration of SVZ progenitors that are induced to divide rapidly (Doetsch et al., 2002; Gonzalez-Perez and Quinones-Hinojosa, 2010). These cells become highly motile Olig2+ cells that travel along blood vessels and axonal tracts, an analogous behavior to that observed in brain tumor cells. Remarkably, none of these studies have reported brain tumor formation, which suggest that the genetic background plays an important role in the potential tumorigenesis of EGF infusion. In summary, it is clear that the excessive signaling of EGF on NSCs induces certain aspects of a transformed phenotype (e.g. proliferation and tissue invasion), but EGF overstimulation by itself is not enough to drive brain tumor formation.
NSCs transplantation has been tested as a cell replacement therapy in several experimental demyelination models with promising results (Keirstead, 2005; Pluchino and Martino, 2005), but delayed rejection of grafted precursor cells is a common event (Barker and Widner, 2004; Ashton-Chess et al., 2006). Therefore, recruitment of oligodendrocytes by stimulation of endogenous NSCs derived from the SVZ may be a feasible alternative for the remyelination of white matter tracts (D'Intino et al., 2006). SVZ oligodendrocyte production increases in response to demyelination, yet cell recruitment into the lesion is not extensive. Remarkably, EGF administration can significantly increase the number of oligodendrocytes derived from Type-B SVZ stem cells, which migrate long distances and contribute to myelin repair. High migration potential and the ability to differentiate into myelin-forming cells have been described as crucial properties in cell repair therapies for demyelinating diseases (Blakemore and Franklin, 2000). Therefore, endogenous stimulation of adult NSCs by EGF may represent a feasible alternative for these degenerative disorders. Nevertheless, future research will be needed to elucidate the role of SVZ progenitors in functional repair after demyelination. In addition, experimental tracking of SVZ stem cells in animals that lack myelin basic protein would be useful to clarify the role of SVZ in remyelination. Understanding the optimal conditions for oligodendrocyte production in the SVZ is a crucial step for designing a stem cell-based therapy.
Acknowledgments
This work was supported by NIH grant HD 32116, the Goldhirsh Foundation, the John G. Bowes Research Fund, and by CONACyT's (Ciencia Basica-2008-101476).
Footnotes
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Contributor Information
Oscar Gonzalez-Perez, Laboratory of Neuroscience. School of Psychology. University of Colima. Colima, Col. 28040, Mexico.
Arturo Alvarez-Buylla, Department of Neurological Surgery. Brain Tumor Research Center. Institute for Regeneration Medicine. University of California, San Francisco, 94143. U.S.A.
  • Aguirre A, Gallo V. Reduced EGFR signaling in progenitor cells of the adult subventricular zone attenuates oligodendrogenesis after demyelination. Neuron Glia Biol. 2007;3:209–220. [PMC free article] [PubMed]
  • Aguirre A, Rubio ME, Gallo V. Notch and EGFR pathway interaction regulates neural stem cell number and self-renewal. Nature. 2010;467:323–327. [PMC free article] [PubMed]
  • Aguirre A, Rizvi TA, Ratner N, Gallo V. Overexpression of the epidermal growth factor receptor confers migratory properties to nonmigratory postnatal neural progenitors. J Neurosci. 2005;25:11092–11106. [PubMed]
  • Aguirre A, Dupree JL, Mangin JM, Gallo V. A functional role for EGFR signaling in myelination and remyelination. Nat Neurosci. 2007;10:990–1002. [PubMed]
  • Ashton-Chess J, Brouard S, Soulillou JP. Is clinical tolerance realistic in the next decade? Transpl Int. 2006;19:539–548. [PubMed]
  • Barker RA, Widner H. Immune problems in central nervous system cell therapy. Neuro Rx. 2004;1:472–481. [PubMed]
  • Bergles DE, Jabs R, Steinhauser C. Neuron-glia synapses in the brain. Brain Res Rev. 2010;63:130–137. [PMC free article] [PubMed]
  • Blakemore WF. The ultrastructure of the subependymal plate in the rat. J Anat. 1969;104:423–433. [PubMed]
  • Blakemore WF, Jolly DR. The subependymal plate and associated ependyma in the dog. An ultrastructural study. J Neurocytol. 1972;1:69–84. [PubMed]
  • Blakemore WF, Franklin RJ. Transplantation options for therapeutic central nervous system remyelination. Cell Transplant. 2000;9:289–294. [PubMed]
  • Burrows RC, Wancio D, Levitt P, Lillien L. Response diversity and the timing of progenitor cell maturation are regulated by developmental changes in EGFR expression in the cortex. Neuron. 1997;19:251–267. [PubMed]
  • Capela A, Temple S. LeX/ssea-1 is expressed by adult mouse CNS stem cells, identifying them as nonependymal. Neuron. 2002;35:865–875. [PubMed]
  • Caric D, Raphael H, Viti J, Feathers A, Wancio D, Lillien L. EGFRs mediate chemotactic migration in the developing telencephalon. Development. 2001;128:4203–4216. [PubMed]
  • Carpenter G, Cohen S. Epidermal growth factor. Annu Rev Biochem. 1979;48:193–216. [PubMed]
  • Cate HS, Sabo JK, Merlo D, Kemper D, Aumann TD, Robinson J, Merson TD, Emery B, Perreau VM, Kilpatrick TJ. Modulation of bone morphogenic protein signalling alters numbers of astrocytes and oligodendroglia in the subventricular zone during cuprizone-induced demyelination. J Neurochem. 2010;115:11–22. [PubMed]
  • Cohen S, Taylor JM. Epidermal growth factor: chemical and biological characterization. Recent Prog Horm Res. 1974;30:533–550. [PubMed]
  • Colak D, Mori T, Brill MS, Pfeifer A, Falk S, Deng C, Monteiro R, Mummery C, Sommer L, Gotz M. Adult neurogenesis requires Smad4-mediated bone morphogenic protein signaling in stem cells. J Neurosci. 2008;28:434–446. [PubMed]
  • Colello RJ, Pott U, Schwab ME. The role of oligodendrocytes and myelin on axon maturation in the developing rat retinofugal pathway. J Neurosci. 1994;14:2594–2605. [PubMed]
  • Craig CG, Tropepe V, Morshead CM, Reynolds BA, Weiss S, Van der Kooy D. In vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adult mouse brain. J Neurosci. 1996;16:2649–2658. [PubMed]
  • D'Intino G, Perretta G, Taglioni A, Calistri M, Falzone C, Baroni M, Giardino L, Calza L. Endogenous stem and precursor cells for demyelinating diseases: an alternative for transplantation? Neurol Res. 2006;28:513–517. [PubMed]
  • Doetsch F. The glial identity of neural stem cells. Nat Neurosci. 2003a;6:1127–1134. [PubMed]
  • Doetsch F. A niche for adult neural stem cells. Curr Opin Genet Dev. 2003b;13:543–550. [PubMed]
  • Doetsch F, Garcia-Verdugo JM, Alvarez-Buylla A. Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain. J Neurosci. 1997;17:5046–5061. [PubMed]
  • Doetsch F, Caille I, Lim DA, García-Verdugo JM, Alvarez-Buylla A. Subventricular Zone Astrocytes Are Neural Stem Cells in the Adult mammalian Brain. Cell. 1999;97:1–20. [PubMed]
  • Doetsch F, Petreanu L, Caille I, Garcia-Verdugo JM, Alvarez-Buylla A. EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells. Neuron. 2002;36:1021–1034. [PubMed]
  • Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn A, Nordborg C, Peterson DA, Gage FH. Neurogenesis in the adult human hippocampus. Nature Medicine. 1998;4:1313–1317. [PubMed]
  • Etxeberria A, Mangin JM, Aguirre A, Gallo V. Adult-born SVZ progenitors receive transient synapses during remyelination in corpus callosum. Nat Neurosci. 2010;13:287–289. [PubMed]
  • Fancy SP, Zhao C, Franklin RJ. Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol Cell Neurosci. 2004;27:247–254. [PubMed]
  • Franklin JD, Lynch JB. Effects of topical applications of epidermal growth factor on wound healing. Experimental study on rabbit ears. Plast Reconstr Surg. 1979;64:766–770. [PubMed]
  • Gadea A, Aguirre A, Haydar TF, Gallo V. Endothelin-1 regulates oligodendrocyte development. J Neurosci. 2009;29:10047–10062. [PMC free article] [PubMed]
  • Garcia-Verdugo JM, Ferron S, Flames N, Collado L, Desfilis E, Font E. The proliferative ventricular zone in adult vertebrates: a comparative study using reptiles, birds, and mammals. Brain Res Bull. 2002;57:765–775. [PubMed]
  • Garcia AD, Doan NB, Imura T, Bush TG, Sofroniew MV. GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain. Nat Neurosci. 2004;7:1233–1241. [PubMed]
  • Gensert JM, Goldman JE. Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron. 1997;19:197–203. [PubMed]
  • Goldman SA, Windrem MS. Cell replacement therapy in neurological disease. Philos Trans R Soc Lond B Biol Sci. 2006;361:1463–1475. [PMC free article] [PubMed]
  • Gonzalez-Perez O, Quinones-Hinojosa A. Dose-dependent effect of EGF on migration and differentiation of adult subventricular zone astrocytes. Glia. 2010;58:975–983. [PMC free article] [PubMed]
  • Gonzalez-Perez O, Romero-Rodriguez R, Soriano-Navarro M, Garcia-Verdugo JM, Alvarez-Buylla A. Epidermal Growth Factor Induces the Progeny of Subventricular Zone Type B Cells to Migrate and Differentiate into Oligodendrocytes. Stem Cells. 2009;27:2032–2043. [PMC free article] [PubMed]
  • Gould E, Reeves AJ, Graziano MSA, Gross CG. Neurogenesis in the neocortex of adult primates. Science. 1999;286:548–552. [PubMed]
  • Gritti A, Cova L, Parati EA, Galli R, Vescovi AL. Basic fibroblast growth factor supports the proliferation of epidermal growth factor-generated neuronal precursor cells of the adult mouse CNS. Neurosci Lett. 1995;185:151–154. [PubMed]
  • Gritti A, Frolichsthal-Schoeller P, Galli R, Parati EA, Cova L, Pagano SF, Bjornson CRR, Vescovi AL. Epidermal and fibroblast growth factors behave as mitogenic regulators for a single multipotent stem cell-like population from the subventricular region of the adult mouse forebrain. J Neurosci. 1999;19:3287–3297. [PubMed]
  • Gritti A, Parati EA, Cova L, Frolichsthal P, Galii R, Wanke E, Faravelli L, Morassutti DJ, Roisen F, Nickel DD, Vescovi AL. Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor. J Neurosci. 1996;16:1091–1100. [PubMed]
  • Guneri EA, Tekin S, Yilmaz O, Ozkara E, Erdag TK, Ikiz AO, Sarioglu S, Guneri A. The effects of hyaluronic acid, epidermal growth factor, and mitomycin in an experimental model of acute traumatic tympanic membrane perforation. Otol Neurotol. 2003;24:371–376. [PubMed]
  • Hack MA, Saghatelyan A, de Chevigny A, Pfeifer A, Ashery-Padan R, Lledo PM, Gotz M. Neuronal fate determinants of adult olfactory bulb neurogenesis. Nat Neurosci. 2005;8:865–872. [PubMed]
  • Holland EC, Varmus HE. Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice. Proc Natl Acad Sci USA. 1998;95:1218–1223. [PubMed]
  • Hosemann W, Wigand ME, Gode U, Langer F, Dunker I. Normal wound healing of the paranasal sinuses: clinical and experimental investigations. Eur Arch Otorhinolaryngol. 1991;248:390–394. [PubMed]
  • Huang L, DeVries GJ, Bittman EL. Photoperiod Regulates Neuronal Bromodeoxyuridine Labeling in the Brain of a Seasonally Breeding Mammal. J Neurobiol. 1998;36:410–420. [PubMed]
  • Ivkovic S, Canoll P, Goldman JE. Constitutive EGFR signaling in oligodendrocyte progenitors leads to diffuse hyperplasia in postnatal white matter. J Neurosci. 2008;28:914–922. [PMC free article] [PubMed]
  • Jablonska B, Aguirre A, Raymond M, Szabo G, Kitabatake Y, Sailor KA, Ming GL, Song H, Gallo V. Chordin-induced lineage plasticity of adult SVZ neuroblasts after demyelination. Nat Neurosci. 2010;13:541–550. [PubMed]
  • Jackson EL, Garcia-Verdugo JM, Gil-Perotin S, Roy M, Quinones-Hinojosa A, VandenBerg S, Alvarez-Buylla A. PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron. 2006;51:187–199. [PubMed]
  • Jijon AJ, Gallup DG, Behzadian MA, Metheny WP. Assessment of epidermal growth factor in the healing process of clean full-thickness skin wounds. Am J Obstet Gynecol. 1989;161:1658–1662. [PubMed]
  • Keirstead HS. Stem cells for the treatment of myelin loss. Trends Neurosci. 2005;28:677–683. [PubMed]
  • Kokovay E, Goderie S, Wang Y, Lotz S, Lin G, Sun Y, Roysam B, Shen Q, Temple S. Adult SVZ lineage cells home to and leave the vascular niche via differential responses to SDF1/CXCR4 signaling. Cell Stem Cell. 2010;7:163–173. [PMC free article] [PubMed]
  • Kolb B, Morshead C, Gonzalez C, Kim M, Gregg C, Shingo T, Weiss S. Growth factor-stimulated generation of new cortical tissue and functional recovery after stroke damage to the motor cortex of rats. J Cereb Blood Flow Metab. 2007;27:983–997. [PubMed]
  • Kornack DR, Rakic P. The generation, migration, and differentiation of olfactory neurons in the adult primate brain. Proc Natl Acad Sci U S A. 2001;98:4752–4757. [PubMed]
  • Kriegstein A, Alvarez-Buylla A. The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci. 2009;32:149–184. [PMC free article] [PubMed]
  • Kuhn HG, Winkler J, Kempermann G, Thal LJ, Gage FH. Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci. 1997;17:5820–5829. [PubMed]
  • Laywell ED, Rakic P, Kukekov VG, Holland EC, Steindler DA. Identification of a multipotent astrocytic stem cell in the immature and adult mouse brain. Proc Natl Acad Sci U S A. 2000;97:13883–13888. [PubMed]
  • Leventhal C, Rafii S, Rafii D, Shahar A, Goldman S. Endothelial Trophic Support of Neuronal Production and Recruitment from the Adult Mammalian Subependyma. Mol Cell Neurosci. 1999;13:450–464. [PubMed]
  • LeVine SM, Goldman JE. Embryonic divergence of oligodendrocyte and astrocyte lineages in developing rat cerebrum. J Neurosci. 1988;8(11):3992–4006. [PubMed]
  • Lewis PD. Mitotic activity in the primate subependymal layer and the genesis of gliomas. Nature. 1968;217:974–975. [PubMed]
  • Ligon KL, Alberta JA, Kho AT, Weiss J, Kwaan MR, Nutt CL, Louis DN, Stiles CD, Rowitch DH. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J Neuropathol Exp Neurol. 2004;63:499–509. [PubMed]
  • Lillien L. Changes in retinal cell fate induced by overexpression of EGF receptor. Nature. 1995;377:158–162. [PubMed]
  • Lim DA, Alvarez-Buylla A. Interaction between astrocytes and adult subventricular zone precursors stimulates neurogenesis. Proc Natl Acad Sci U S A. 1999;96:7526–7531. [PubMed]
  • Lim DA, Huang YC, Alvarez-Buylla A. The adult neural stem cell niche: lessons for future neural cell replacement strategies. Neurosurg Clin N Am. 2007;18:81–92. ix. [PubMed]
  • Lindsay CD. Novel therapeutic strategies for acute lung injury induced by lung damaging agents: The potential role of growth factors as treatment options. Hum Exp Toxicol 2010 [PubMed]
  • Lois C, Alvarez-Buylla A. Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc Natl Acad Sci U S A. 1993;90:2074–2077. [PubMed]
  • Lois C, Alvarez-Buylla A. Long-distance neuronal migration in the adult mammalian brain. Science. 1994;264:1145–1148. [PubMed]
  • Lois C, Garcia-Verdugo JM, Alvarez-Buylla A. Chain migration of neuronal precursors. Science. 1996;271:978–981. [PubMed]
  • Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 2001;15:1311–1333. [PubMed]
  • Maire CL, Wegener A, Kerninon C, Nait-Oumesmar B. Gain-of-Function of Olig Transcription Factors Enhances Oligodendrogenesis and Myelination. Stem Cells 2010 [PubMed]
  • Marie Y, Sanson M, Mokhtari K, Leuraud P, Kujas M, Delattre JY, Poirier J, Zalc B, Hoang-Xuan K. OLIG2 as a specific marker of oligodendroglial tumour cells. Lancet. 2001;358:298–300. [PubMed]
  • Mathis C, Denisenko-Nehrbass N, Girault JA, Borrelli E. Essential role of oligodendrocytes in the formation and maintenance of central nervous system nodal regions. Development. 2001;128:4881–4890. [PubMed]
  • McDermott KWG, Lantos PL. Cell proliferation in the subependymal layer of the postnatal marmoset, Callithrix jacchus. Dev Brain Res. 1990;57:269–277. [PubMed]
  • Menn B, Garcia-Verdugo JM, Yaschine C, Gonzalez-Perez O, Rowitch D, Alvarez-Buylla A. Origin of oligodendrocytes in the subventricular zone of the adult brain. J Neurosci. 2006;26:7907–7918. [PubMed]
  • Mercier F, Kitasako JT, Hatton GI. Anatomy of the brain neurogenic zones revisited: fractones and the fibroblast/macrophage network. J Comp Neurol. 2002;451:170–188. [PubMed]
  • Merkle FT, Mirzadeh Z, Alvarez-Buylla A. Mosaic organization of neural stem cells in the adult brain. Science. 2007;317:381–384. [PubMed]
  • Mirzadeh Z, Merkle FT, Soriano-Navarro M, Garcia-Verdugo JM, Alvarez-Buylla A. Neural stem cells confer unique pinwheel architecture to the ventricular surface in neurogenic regions of the adult brain. Cell Stem Cell. 2008;3:265–278. [PMC free article] [PubMed]
  • Mustoe TA, Pierce GF, Morishima C, Deuel TF. Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model. J Clin Invest. 1991;87:694–703. [PMC free article] [PubMed]
  • Nait-Oumesmar B, Decker L, Lachapelle F, Avellana-Adalid V, Bachelin C, Van Evercooren AB. Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. Eur J Neurosci. 1999;11:4357–4366. [PubMed]
  • Nait-Oumesmar B, Picard-Riera N, Kerninon C, Decker L, Seilhean D, Hoglinger GU, Hirsch EC, Reynolds R, Baron-Van Evercooren A. Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proc Natl Acad Sci U S A. 2007;104:4694–4699. [PubMed]
  • Nery S, Wichterle H, Fishell G. Sonic hedgehog contributes to oligodendrocyte specification in the mammalian forebrain. Development. 2001;128:527–540. [PubMed]
  • Nishiyama A, Watanabe M, Yang Z, Bu J. Identity, distribution, and development of polydendrocytes: NG2-expressing glial cells. J Neurocytol. 2002;31:437–455. [PubMed]
  • Nishiyama A, Komitova M, Suzuki R, Zhu X. Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat Rev Neurosci. 2009;10:9–22. [PubMed]
  • Nunes MC, Roy NS, Keyoung HM, Goodman RR, McKhann G, 2nd, Jiang L, Kang J, Nedergaard M, Goldman SA. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat Med. 2003;9:439–447. [PubMed]
  • Petratos S, Gonzales MF, Azari MF, Marriott M, Minichiello RA, Shipham KA, Profyris C, Nicolaou A, Boyle K, Cheema SS, Kilpatrick TJ. Expression of the low-affinity neurotrophin receptor, p75(NTR), is upregulated by oligodendroglial progenitors adjacent to the subventricular zone in response to demyelination. Glia. 2004;48:64–75. [PubMed]
  • Petroutsos G, Courty J, Guimaraes R, Pouliquen Y, Barritault D, Plouet J, Courtois Y. Comparison of the effects of EGF, pFGF and EDGF on corneal epithelium wound healing. Curr Eye Res. 1984;3:593–598. [PubMed]
  • Petryniak MA, Potter GB, Rowitch DH, Rubenstein JL. Dlx1 and Dlx2 control neuronal versus oligodendroglial cell fate acquisition in the developing forebrain. Neuron. 2007;55:417–433. [PMC free article] [PubMed]
  • Picard-Riera N, Decker L, Delarasse C, Goude K, Nait-Oumesmar B, Liblau R, Pham-Dinh D, Evercooren AB. Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice. Proc Natl Acad Sci U S A. 2002;99:13211–13216. [PubMed]
  • Pluchino S, Martino G. The therapeutic use of stem cells for myelin repair in autoimmune demyelinating disorders. J Neurol Sci. 2005;233:117–119. [PubMed]
  • Pluchino S, Quattrini A, Brambilla E, Gritti A, Salani G, Dina G, Galli R, Del Carro U, Amadio S, Bergami A, Furlan R, Comi G, Vescovi AL, Martino G. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature. 2003;422:688–694. [PubMed]
  • Povlsen GK. The Neural Cell Adhesion Molecule and Epidermal Growth Factor Receptor: Signaling Crosstalk. Neurochem Res 2008 [PubMed]
  • Povlsen GK. The neural cell adhesion molecule and epidermal growth factor receptor: signaling crosstalk. Adv Exp Med Biol. 2010;663:199–209. [PubMed]
  • Pringle NP, Mudhar HS, Collarini EJ, Richardson WD. PDGF receptors in the rat CNS: during late neurogenesis, PDGF alpha-receptor expression appears to be restricted to glial cells of the oligodendrocyte lineage. Development. 1992;115:535–551. [PubMed]
  • Quinones-Hinojosa A, Sanai N, Soriano-Navarro M, Gonzalez-Perez O, Mirzadeh Z, Gil-Perotin S, Romero-Rodriguez R, Berger MS, Garcia-Verdugo JM, Alvarez-Buylla A. Cellular composition and cytoarchitecture of the adult human subventricular zone: a niche of neural stem cells. J Comp Neurol. 2006;494:415–434. [PubMed]
  • Reynolds B, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science. 1992;255:1707–1710. [PubMed]
  • Richardson WD, Kessaris N, Pringle N. Oligodendrocyte wars. Nat Rev Neurosci. 2006;7:11–18. [PubMed]
  • Rietze RL, Valcanis H, Brooker GF, Thomas T, Voss AK, Bartlett PF. Purification of a pluripotent neural stem cell from the adult mouse brain. Nature. 2001;412:736–739. [PubMed]
  • Rodriguez-Perez LM, Perez-Martin M, Jimenez AJ, Fernandez-Llebrez P. Immunocytochemical characterisation of the wall of the bovine lateral ventricle. Cell Tissue Res. 2003;314:325–335. [PubMed]
  • Rowitch DH. Glial specification in the vertebrate neural tube. Nat Rev Neurosci. 2004;5:409–419. [PubMed]
  • Sanai N, Tramontin AD, Quinones-Hinojosa A, Barbaro NM, Gupta N, Kunwar S, Lawton MT, McDermott MW, Parsa AT, Manuel-Garcia Verdugo J, Berger MS, Alvarez-Buylla A. Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature. 2004;427:740–744. [PubMed]
  • Seroogy KB, Lundgren KH, Lee DC, Guthrie KM, Gall CM. Cellular localization of transforming growth factor-α mRNA in rat forebrain. Journal of Neurochemistry. 1993;60:1777–1782. [PubMed]
  • Shen Q, Wang Y, Kokovay E, Lin G, Chuang SM, Goderie SK, Roysam B, Temple S. Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions. Cell Stem Cell. 2008;3:289–300. [PMC free article] [PubMed]
  • Stallcup WB, Beasley L. Bipotential glial precursor cells of the optic nerve express the NG2 proteoglycan. J Neurosci. 1987;7:2737–2744. [PubMed]
  • Sun Y, Goderie SK, Temple S. Asymmetric distribution of EGFR receptor during mitosis generates diverse CNS progenitor cells. Neuron. 2005;45:873–886. [PubMed]
  • Taupin P. The therapeutic potential of adult neural stem cells. Curr Opin Mol Ther. 2006;8:225–231. [PubMed]
  • Tavazoie M, Van der Veken L, Silva-Vargas V, Louissaint M, Colonna L, Zaidi B, Garcia-Verdugo JM, Doetsch F. A specialized vascular niche for adult neural stem cells. Cell Stem Cell. 2008;3:279–288. [PubMed]
  • Tropepe V, Craig CG, Morshead CM, Van der Kooy D. Transforming growth factor-α null and senescent mice show decreased neural progenitor cell proliferation in the forebrain subependyma. J Neurosci. 1997;17:7850–7859. [PubMed]
  • Vescovi AL, Reynolds BA, Fraser DD, Weiss S. bFGF regulates the proliferative fate of unipotent (neuronal) and bipotent (neuronal/astroglial) EGF-generated CNS progenitor cells. Neuron. 1993;11:951–966. [PubMed]
  • Wechsler-Reya R, Scott MP. The developmental biology of brain tumors. Annu Rev Neurosci. 2001;24:385–428. [PubMed]
  • Wigley R, Butt AM. Integration of NG2-glia (synantocytes) into the neuroglial network. Neuron Glia Biol. 2009;5:21–28. [PubMed]
  • Zawadzka M, Rivers LE, Fancy SP, Zhao C, Tripathi R, Jamen F, Young K, Goncharevich A, Pohl H, Rizzi M, Rowitch DH, Kessaris N, Suter U, Richardson WD, Franklin RJ. CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell. 2010;6:578–590. [PubMed]